FDA approves GSK myelofibrosis drug

The latest stories trending on MedCity News.

Editor's Pick

Top Story FDA Approves GSK Myelofibrosis Med That Has Edge Over Others in Drug Class FDA approval of GSK's Ojjaara in myelofibrosis introduces a new competitor to blockbuster Incyte drug Jakafi. Ojjaara was part of GSK's $1.9 billion acquisition of Sierra Oncology last year. Sponsored Content Navigating Healthcare's Data Revolution: Priorities, Opportunities, and Challenges for Health Systems Presented by Arcadia Arcadia recently partnered with HIMSS Market Insights to survey executives, IT, technology, and clinical leaders. Here's what we found. Learn More>> Hurry, Your Chance to Save $100 Ends on 9/22 Network with the best, connect with investors, find new partners, checkout the latest innovative startups in FemTech, participate in riveting panel discussions and so much more. Don't miss this great opportunity to further yourself and your organization. Join us October 26th at Pegasus Park in Dallas. Reserve Your Seat Now

Featured News

Can AI Compose Clinical Documentation? Absolutely, but with Limits. A recent academic study of the leading LLM AI models' ability to read and interpret clinical information demonstrates the incredible power of these tools to support healthcare, but concludes that LLMs should be used as "a supplement to existing workflows rather than as a replacement for human expertise." How care orchestration technology improves the perioperative care process It is no longer a question of whether we should use automation for care orchestration. The technology for intelligent automation of care coordination is available now and can help providers reduce costs, generate revenue, and overcome understaffing. CMS Is Getting More Serious About Penalizing Hospitals For Price Transparency Noncompliance CMS has fined two hospitals in September for alleged violations of its price transparency rule. This marks the third month in a row that the agency has issued fines against hospitals for price transparency noncompliance, following a yearslong period of light enforcement. Introducing MedCity FemFwd, a New Podcast on Women's Health MedCity News is launching a new podcast called MedCity FemFwd, which will discuss the breakthroughs and challenges in the women's health space. In the inaugural episode, Michelle Long of KFF examines whether Opill — the first daily oral contraceptive approved for nonprescription use in the U.S. — will be covered by insurance.

Resources

Achieve Full HIPAA Compliance With the Help of This Checklist With our free HIPAA checklist, you can effortlessly pinpoint your compliance status and identify any remaining steps needed to achieve full HIPAA compliance. Get started today and easily find out where you stand and what else needs to be done! Download Now

MedCity News • PO Box 901 • New York, NY unsubscribe